(Q46383780)
Statements
1 reference
Anti-PCSK9 monotherapy for hypercholesterolemia: the MENDEL-2 randomized, controlled phase III clinical trial of evolocumab (English)
1 reference
Michael J Koren
Pernille Lundqvist
Michael Bolognese
Joel M Neutel
Maria Laura Monsalvo
Jingyuan Yang
Jae B Kim
Scott M Wasserman
Harold Bays
MENDEL-2 Investigators
29 March 2014
1 reference